Samsung Biologics Co., Ltd. (207940)
KRX
Closed
Aug 25, 2026
Day's Range
1,537,000.0052 wk Range
1,228,000.00Overview - 207940 - Samsung Biologics Co., Ltd.
Key Statistics
Valuation
Enterprise Value
70.74T
P/E (Trailing)
‪59.07‬
P/E (Forward)
‪31.89‬
PEG Ratio
‪0.63‬
Price / Sales (TTM)
‪14.01‬
Price / Book
‪9.18‬
EV / EBITDA
‪25.01‬
Profitability
Gross Margin
‪54.08%‬
Profit Margin
‪38.74%‬
Operating Margin
‪44.39%‬
Return on Assets
‪9.56%‬
Return on Equity
‪18.52%‬
Ownership
Shares Outstanding
46.23M
Float
11.79M
Held by Insiders
‪74.37%‬
Held by Institutions
‪16.44%‬
Price stats
50-Day Avg
‪1,434,280.00‬
200-Day Avg
‪1,594,593.20‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
25 analysts
Average price target
‪₩ 1,975,520.00‬Market Cap - 207940 - Samsung Biologics Co., Ltd.
Peers - 207940 - Samsung Biologics Co., Ltd.
Peer Comparison
Compared with companies in Biotechnology listed on KRX.
- 207940KRXSamsung Biologics Co., Ltd.72.81TMarket Cap+0.40%52-week change59.07P/E (Trailing)‪38.74%‬Profit Margin
- 068270KRXCelltrion Inc.44.48TMarket Cap+14.43%52-week change43.64P/E (Trailing)‪32.18%‬Profit Margin
- 196170KRXALTEOGEN Inc.22.29TMarket Cap-5.12%52-week change157.05P/E (Trailing)‪63.89%‬Profit Margin
- 0126Z0KRXSamsung Epis Holdings Co., Ltd.9.16TMarket Cap-19.00%52-week change—P/E (Trailing)‪33.89%‬Profit Margin
- 326030KRXSk Biopharmaceuticals Co., Ltd.6.76TMarket Cap-16.32%52-week change25.34P/E (Trailing)‪44.13%‬Profit Margin
- 028300KRXHLB Co., Ltd.5.02TMarket Cap+2.11%52-week change-22.53P/E (Trailing)‪-228.04%‬Profit Margin
- 214450KRXPharma Research Products Co., Ltd4.32TMarket Cap-66.83%52-week change26.18P/E (Trailing)‪31.21%‬Profit Margin
Profile Summary - 207940 - Samsung Biologics Co., Ltd.
About
Samsung Biologics Co., Ltd. is a leading global contract development and manufacturing organization (CDMO) specializing in biopharmaceuticals. Headquartered in Incheon, South Korea, the company provides end-to-end services from cell line development and process development to large-scale commercial manufacturing and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
